News

Preclinical Clues May Speed Parkinson's Diagnosis

Publish date: November 1, 2007
PDF Download

 

Imaging can detect asymptomatic neurologic changes. A SPECT scan of a patient with early PD shows reduced dopamine transporter binding on the as-yet unaffected side. Danna Jennings/Ken Marek/The Institute for Neurodegeneration

Pages

Recommended Reading

Serial PET Predicted PD-Induced Cognitive Loss
MDedge Neurology
Higher Suicide Rates Reported in Parkinson's Patients After DBS
MDedge Neurology
Dopamine Agonist/Levodopa Combo Linked to Compulsions
MDedge Neurology
PD Guidelines: Therapy Do's and Don't Bother's
MDedge Neurology
Tolcapone's Approved Label Changes Mean Less Liver Enzyme Monitoring
MDedge Neurology
Frequency, Pain of Restless Legs Should Guide Therapy
MDedge Neurology
FDA Approves Use of MAO Inhibitor for Parkinson's
MDedge Neurology
Deep-Brain Stimulation Aids Quality of Life in PD
MDedge Neurology
Parkinson's Rotigotine Patch Treatment Approved
MDedge Neurology
Infections, Drug Changes Cause the Biggest Problems for PD
MDedge Neurology